La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Dose-Response Relationship, Drug »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopaminergic Neurons (virology) < Dose-Response Relationship, Drug < Dose-Response Relationship, Radiation  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 61.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000620 (2006) Emuri Abe ; Jean-Claude AlvarezSensitive quantification of apomorphine in human plasma using a LC-ESI-MS-MS method.
000650 (2006) Olivier Rascol [France] ; Bruno Dubois ; Alexandre Castro Caldas ; Stephen Senn ; Susanna Del Signore ; Andrew LeesEarly piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
000657 (2006) Mauricette Brocco [France] ; Anne Dekeyne ; Mariusz Papp ; Mark J. MillanAntidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
000672 (2006) D. Devos ; P. Krystkowiak ; F. Clement ; K. Dujardin ; O. Cottencin ; N. Waucquier ; K. Ajebbar ; B. Thielemans ; M. Kroumova ; A. Duhamel ; A. Destée ; R. Bordet ; L. DefebvreImprovement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease
000750 (2007) Lionel J. Velly [France] ; Marc F. Rey ; Nicolas J. Bruder ; François A. Gouvitsos ; Tatiana Witjas ; Jean Marie Regis ; Jean Claude Peragut ; François M. GouinDifferential dynamic of action on cortical and subcortical structures of anesthetic agents during induction of anesthesia.
000780 (2007) G. Villafane [France] ; P. Cesaro ; A. Rialland ; S. Baloul ; S. Azimi ; C. Bourdet ; J. Le Houezec ; I. Macquin-Mavier ; P. MaisonChronic high dose transdermal nicotine in Parkinson's disease: an open trial.
000797 (2007) Jean-Christophe Corvol [France] ; Jean-Baptiste Anzouan-Kacou ; Elodie Fauveau ; Anne-Marie Bonnet ; Bénédicte Lebrun-Vignes ; Camille Girault ; Yves Agid [France] ; Philippe Lechat ; Richard Isnard ; Lucette LacomblezHeart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
000852 (2008) J-P Azulay [France] ; F. Durif ; R. Rogez ; C. Tranchant ; I. Bourdeix ; K. Rerat[Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations].
000858 (2008) Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees ; Marina Aristin ; Laurence Salin ; Nolwenn Juhel ; Lisa Waldhauser ; Thomas SchindlerTesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.
000973 (2009) Olivier Rascol [France] ; Santiago Perez-LloretRotigotine transdermal delivery for the treatment of Parkinson's disease.
000974 (2009) Hélène Gervais-Bernard [France] ; Jing Xie-Brustolin ; Patrick Mertens ; Gustavo Polo ; Hélène Klinger ; Dario Adamec ; Emmanuel Broussolle ; Stéphane ThoboisBilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up.
000984 (2009) Serena Santucci [France] ; Nicole Zsürger ; Joëlle Chabrybeta-N-methylamino-L-alanine induced in vivo retinal cell death.
000A04 (2009) Emmanuel Itti [France] ; Gabriel Villafane ; Zoulikha Malek ; Pierre Brugières ; Daniela Capacchione ; Laurent Itti ; Patrick Maison ; Pierre Cesaro ; Michel MeignanDopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study.
000A14 (2009) Dario Cuomo [France] ; Giuseppina Martella ; Emanuela Barabino ; Paola Platania ; Daniela Vita ; Graziella Madeo ; Chelliah Selvam ; Cyril Goudet ; Nadia Oueslati ; Jean-Philippe Pin ; Francine Acher ; Antonio Pisani ; Corinne Beurrier ; Christophe Melon ; Lydia Kerkerian-Le Goff ; Paolo GubelliniMetabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
000B01 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay ; Olivier Blin ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Pierre Césaro ; Philippe Damier ; Bérengère Debilly ; Frank Durif ; Monique Galitzky ; Jean-Marie Grouin ; Sylvie Pennaforte ; Gabriel Villafane ; Sadek Yaici ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
000B84 (2010) Olivier Rascol [France] ; Paolo Barone ; Robert A. Hauser ; Yoshikuni Mizuno ; Werner Poewe [Autriche] ; Anthony H V. Schapira ; Laurence Salin ; Mandy Sohr ; Catherine DebieuvreEfficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
000D54 (1990) G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. MontastrucBeta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
000E18 (2012) N. Carrière [France] ; A. Kreisler ; K. Dujardin ; A. Destée ; L. Defebvre[Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
000E88 (2013) Khaled-Ezaheir Bennouar [France] ; Michelle A. Uberti ; Christophe Melon ; Maria D. Bacolod ; Hermogenes N. Jimenez ; Manuel Cajina ; Lydia Kerkerian-Le Goff ; Darío Doller ; Paolo GubelliniSynergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
000F66 (2012) Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. MolineDonepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
001105 (2013) Suzanne Lesage [France] ; Mathieu Anheim ; Franck Letournel ; Luc Bousset ; Aurélie Honoré ; Nelly Rozas ; Laura Pieri ; Karine Madiona ; Alexandra Dürr ; Ronald Melki ; Christophe Verny ; Alexis BriceG51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dose-Response Relationship, Drug" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dose-Response Relationship, Drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dose-Response Relationship, Drug
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024